Qsemble Capital Management LP Acquires Shares of 46,715 The Cooper Companies, Inc. (NASDAQ:COO)

Qsemble Capital Management LP acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 46,715 shares of the medical device company's stock, valued at approximately $4,078,000. Cooper Companies accounts for 0.8% of Qsemble Capital Management LP's investment portfolio, making the stock its 20th largest holding.

• 3 Mortgage Companies To Watch On Rising Home Sales

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in shares of Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company's stock worth $2,343,723,000 after buying an additional 17,367,502 shares during the period. Capital World Investors raised its holdings in shares of Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company's stock worth $573,657,000 after buying an additional 4,246,519 shares during the period. Janus Henderson Group PLC raised its holdings in shares of Cooper Companies by 279.8% in the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company's stock worth $348,723,000 after buying an additional 2,532,186 shares during the period. Bessemer Group Inc. raised its holdings in shares of Cooper Companies by 305.2% in the first quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company's stock worth $203,013,000 after buying an additional 1,507,049 shares during the period. Finally, Swedbank AB bought a new position in Cooper Companies in the first quarter worth approximately $139,246,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on COO. Stifel Nicolaus reissued a "buy" rating and issued a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler increased their price objective on Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Thursday, August 29th. Wells Fargo & Company increased their price objective on Cooper Companies from $110.00 to $115.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Finally, Morgan Stanley increased their price objective on Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a research note on Tuesday. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $115.00.

Read Our Latest Research Report on Cooper Companies

Cooper Companies Stock Up 0.2 %

Shares of NASDAQ COO opened at $108.51 on Thursday. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The stock has a market capitalization of $21.61 billion, a PE ratio of 63.83, a price-to-earnings-growth ratio of 2.55 and a beta of 0.98. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $108.68. The stock's fifty day simple moving average is $94.63 and its two-hundred day simple moving average is $94.87.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analysts' expectations of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business's quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.84 EPS. As a group, analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Insider Transactions at Cooper Companies

In other news, COO Daniel G. Mcbride sold 114,992 shares of the firm's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CFO Brian G. Andrews sold 24,788 shares of the firm's stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total value of $2,625,049.20. Following the completion of the transaction, the chief financial officer now owns 6,614 shares in the company, valued at approximately $700,422.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Daniel G. Mcbride sold 114,992 shares of the firm's stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the completion of the transaction, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. The disclosure for this sale can be found here. Insiders sold 141,381 shares of company stock valued at $14,927,361 in the last quarter. 2.00% of the stock is currently owned by corporate insiders.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

• Five stocks we like better than Cooper Companies
• What is the Euro STOXX 50 Index?
• Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
• 2 Fintech Stocks to Buy Now and 1 to Avoid
• GameStop: Earnings Won’t Save It, Dilution Points to Trouble
• How Technical Indicators Can Help You Find Oversold Stocks
• Dividend Aristocrats or Dividend Kings: Which Is Best for You?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ Invest before this deal closes on 9/18 (From Deal Maker) (Ad)

Should you invest $1,000 in Cooper Companies right now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here